Latest Market News

Kore Potash has raised approximately US$12.2 million through a new share issue to fund critical project payments and maintain working capital for the next year. The fundraise also opens the door for major shareholders to increase their stakes, pending approvals.

Mastermyne’s FY2025 AGM reveals resilience amid sector headwinds, operational disruptions, and legal proceedings, while positioning for growth with new leadership and contracts.

US Masters Residential Property Group has surpassed its 2025 sales target with over US$200 million in property sales and significantly reduced its debt, while maintaining steady distributions to investors.

Cuscal Limited has received final regulatory approval from APRA for its full acquisition of Indue Limited, setting the stage for completion by early December.

DGL Group Limited has outlined a clear path to regain its ASX listing following suspension, targeting reinstatement by February or March 2026 pending audit outcomes.

Champion Iron Limited has updated its dividend announcement, confirming an ordinary dividend of CAD 0.10 per share and its Australian Dollar equivalent for the first half of 2025.

Talga Group has received a significant A$13.35 million grant from the Swedish Energy Agency to advance its sustainable battery anode manufacturing project, aiming for near-industrial scale validation by mid-2026.

FSA Group Ltd reports robust growth in loan origination and loan pools, driven by car loans and asset finance, while raising profit guidance for FY2026. The company’s strategic focus on automation and offshore expansion underpins its ambitious $1.3 billion loan pool target.

Elders Limited has updated its dividend announcement, confirming a fully franked 18-cent per share payout and setting the Dividend Reinvestment Plan election deadline for November 28.

Kaili Resources has reported significant rare earth element assay results from its recent aircore drilling program in South Australia’s Limestone Coast region, highlighting notable TREO concentrations that suggest strong exploration potential.

Monash IVF Group reported a 6.7% revenue increase to $271.9 million for FY25, alongside an 8.1% decline in underlying NPAT, aligning with prior guidance. The company outlined a cautious FY26 outlook focused on innovation, doctor retention, and cost management.

Monash IVF Group reported solid FY25 revenue and EBITDA growth despite sector softness and clinical incidents, while announcing a leadership transition and dividend pause.